Hyperamylasaemia and dual paraneoplastic syndromes in small cell lung cancer
- PMID: 24048720
- DOI: 10.1177/0004563213500658
Hyperamylasaemia and dual paraneoplastic syndromes in small cell lung cancer
Abstract
We hereby describe the rare case of a 59-year-old patient presenting with marked hyperamylasaemia mimicking acute pancreatitis upon admission. Investigation of co-existent hypokalemia revealed the presence of ectopic adrenocorticotropic hormone secretion, leading to the final diagnosis of small cell lung cancer, exhibiting dual paraneoplastic syndromes including Cushing Syndrome and hyperamylasaemia. Although, paraneoplastic syndromes occur commonly, paraneoplastic hyperamylasaemia especially in the context of dual paraneoplastic syndromes occurring simultaneously, is extremely rare. Such misleading manifestations require a high index of suspicion on behalf of the physician, so that an underlying malignancy is not missed, and a final diagnosis combining all clinical and laboratory findings is reached. In turn, in rare cases common biochemical markers such as amylase can be used as a useful follow up index driving further management.
Keywords: Amylase; cancer; tumour markers.
Comment in
-
Hyperamylasaemia: don't forget undiagnosed carcinoma.Ann Clin Biochem. 2014 Jan;51(Pt 1):5-7. doi: 10.1177/0004563213510490. Epub 2013 Nov 5. Ann Clin Biochem. 2014. PMID: 24194585 No abstract available.
-
Malignancy-associated hyperamylasaemia.Ann Clin Biochem. 2014 Sep;51(Pt 5):619. doi: 10.1177/0004563214531402. Epub 2014 Apr 24. Ann Clin Biochem. 2014. PMID: 24763853 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
